Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Sunesis Pharmaceuticals Inc (NASDAQ:SNSS)

1.40
Delayed Data
As of Jul 31
 -0.075 / -5.10%
Today’s Change
0.84
Today|||52-Week Range
8.46
-45.29%
Year-to-Date

Today’s Trading

Previous close1.47
Today’s open1.50
Day’s range1.32 - 1.53
Volume4,271,488
Average volume (3 months)2,204,658
Market cap$105.3M
Dividend yield--
Data as of 3:59pm ET, 07/31/2015

Growth & Valuation

Earnings growth (last year)-15.15%
Earnings growth (this year)+31.20%
Earnings growth (next 5 years)--
Revenue growth (last year)-27.93%
P/E ratioNM
Price/Sales27.35
Price/Book6.68

Competitors

 Today’s
change
Today’s
% change
CPIXCumberland Pharmaceu...+0.24+4.01%
CTRVContraVir Pharmaceut...-0.25-4.95%
ARQLArQule Inc+0.08+4.91%
PVCTProvectus Biopharmac...+0.01+1.98%
Data as of 3:59pm ET, 07/31/2015

Financials

Next reporting dateNovember 16, 2015
EPS forecast (this quarter)-$0.13
Annual revenue (last year)$5.7M
Annual profit (last year)-$43.0M
Net profit margin-749.95%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Daniel N. Swisher
CFO, Secretary &
EVP-Corporate Development
Eric H. Bjerkholt
Corporate headquarters
South San Francisco, California

Forecasts